S&P 500   3,921.35 (-0.69%)
DOW   31,871.54 (-0.73%)
QQQ   308.15 (-0.52%)
AAPL   158.74 (-0.12%)
MSFT   278.47 (+0.29%)
META   205.25 (+0.47%)
GOOGL   104.68 (-0.87%)
AMZN   96.92 (-1.81%)
TSLA   189.28 (-1.53%)
NVDA   265.79 (-2.25%)
NIO   9.02 (-2.70%)
BABA   86.55 (+0.03%)
AMD   97.64 (-2.63%)
T   18.40 (-0.33%)
F   11.34 (-0.70%)
MU   61.12 (-0.36%)
CGC   1.91 (+0.00%)
GE   91.32 (-0.29%)
DIS   93.25 (-2.69%)
AMC   4.42 (-1.12%)
PFE   40.00 (-0.45%)
PYPL   72.66 (+0.14%)
NFLX   328.99 (+2.69%)
S&P 500   3,921.35 (-0.69%)
DOW   31,871.54 (-0.73%)
QQQ   308.15 (-0.52%)
AAPL   158.74 (-0.12%)
MSFT   278.47 (+0.29%)
META   205.25 (+0.47%)
GOOGL   104.68 (-0.87%)
AMZN   96.92 (-1.81%)
TSLA   189.28 (-1.53%)
NVDA   265.79 (-2.25%)
NIO   9.02 (-2.70%)
BABA   86.55 (+0.03%)
AMD   97.64 (-2.63%)
T   18.40 (-0.33%)
F   11.34 (-0.70%)
MU   61.12 (-0.36%)
CGC   1.91 (+0.00%)
GE   91.32 (-0.29%)
DIS   93.25 (-2.69%)
AMC   4.42 (-1.12%)
PFE   40.00 (-0.45%)
PYPL   72.66 (+0.14%)
NFLX   328.99 (+2.69%)
S&P 500   3,921.35 (-0.69%)
DOW   31,871.54 (-0.73%)
QQQ   308.15 (-0.52%)
AAPL   158.74 (-0.12%)
MSFT   278.47 (+0.29%)
META   205.25 (+0.47%)
GOOGL   104.68 (-0.87%)
AMZN   96.92 (-1.81%)
TSLA   189.28 (-1.53%)
NVDA   265.79 (-2.25%)
NIO   9.02 (-2.70%)
BABA   86.55 (+0.03%)
AMD   97.64 (-2.63%)
T   18.40 (-0.33%)
F   11.34 (-0.70%)
MU   61.12 (-0.36%)
CGC   1.91 (+0.00%)
GE   91.32 (-0.29%)
DIS   93.25 (-2.69%)
AMC   4.42 (-1.12%)
PFE   40.00 (-0.45%)
PYPL   72.66 (+0.14%)
NFLX   328.99 (+2.69%)
S&P 500   3,921.35 (-0.69%)
DOW   31,871.54 (-0.73%)
QQQ   308.15 (-0.52%)
AAPL   158.74 (-0.12%)
MSFT   278.47 (+0.29%)
META   205.25 (+0.47%)
GOOGL   104.68 (-0.87%)
AMZN   96.92 (-1.81%)
TSLA   189.28 (-1.53%)
NVDA   265.79 (-2.25%)
NIO   9.02 (-2.70%)
BABA   86.55 (+0.03%)
AMD   97.64 (-2.63%)
T   18.40 (-0.33%)
F   11.34 (-0.70%)
MU   61.12 (-0.36%)
CGC   1.91 (+0.00%)
GE   91.32 (-0.29%)
DIS   93.25 (-2.69%)
AMC   4.42 (-1.12%)
PFE   40.00 (-0.45%)
PYPL   72.66 (+0.14%)
NFLX   328.99 (+2.69%)
NASDAQ:PAHC

Phibro Animal Health - PAHC Stock Forecast, Price & News

$14.54
+0.01 (+0.07%)
(As of 03/24/2023 10:39 AM ET)
Add
Compare
Today's Range
$14.35
$14.63
50-Day Range
$14.52
$16.37
52-Week Range
$11.75
$20.68
Volume
7,334 shs
Average Volume
116,000 shs
Market Capitalization
$588.87 million
P/E Ratio
16.16
Dividend Yield
3.30%
Price Target
$18.00

Phibro Animal Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
23.8% Upside
$18.00 Price Target
Short Interest
Healthy
2.44% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-3.93
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
9.60%
From $1.25 to $1.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Medical Sector

240th out of 989 stocks

Pharmaceutical Preparations Industry

100th out of 480 stocks


PAHC stock logo

About Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment consists of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
PAHC.A - | Stock Price & Latest News | Reuters
Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass
Phibro Animal Health (PAHC) Misses Q1 Earnings Estimates
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Company Calendar

Last Earnings
2/08/2023
Ex-Dividend for 3/22 Dividend
2/28/2023
Dividend Payable
3/22/2023
Today
3/24/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAHC
Employees
1,860
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$19.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+23.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$49.17 million
Pretax Margin
5.84%

Debt

Sales & Book Value

Annual Sales
$972.05 million
Cash Flow
$2.09 per share
Book Value
$6.48 per share

Miscellaneous

Free Float
20,228,000
Market Cap
$588.52 million
Optionable
Optionable
Beta
0.60

Key Executives

  • Jack C. Bendheim
    Chairman, President & Chief Executive Officer
  • Larry L. Miller
    Chief Operating Officer
  • Damian Finio
    Chief Financial Officer
  • Thomas G. Dagger
    Secretary, Senior Vice President & General Counsel
  • Mona Desai
    Vice President & Controller













PAHC Stock - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings
or view top-rated stocks.

What is Phibro Animal Health's stock price forecast for 2023?

3 brokers have issued twelve-month price targets for Phibro Animal Health's stock. Their PAHC share price forecasts range from $17.00 to $19.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests a possible upside of 23.9% from the stock's current price.
View analysts price targets for PAHC
or view top-rated stocks among Wall Street analysts.

How have PAHC shares performed in 2023?

Phibro Animal Health's stock was trading at $13.41 at the start of the year. Since then, PAHC shares have increased by 8.4% and is now trading at $14.53.
View the best growth stocks for 2023 here
.

When is Phibro Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our PAHC earnings forecast
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) announced its quarterly earnings results on Wednesday, February, 8th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.04. The business earned $244.60 million during the quarter, compared to the consensus estimate of $238.44 million. Phibro Animal Health had a trailing twelve-month return on equity of 18.90% and a net margin of 3.73%.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, February 6th. Investors of record on Wednesday, March 1st will be given a dividend of $0.12 per share on Wednesday, March 22nd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date is Tuesday, February 28th.
Read our dividend analysis for PAHC
.

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.20%. The dividend payout ratio is 53.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 35.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY 2023 earnings guidance on Wednesday, February, 8th. The company provided earnings per share guidance of $1.21-$1.31 for the period, compared to the consensus EPS estimate of $1.20. The company issued revenue guidance of $960.00M-$1.00 billion, compared to the consensus revenue estimate of $982.11 million.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (4.86%), Heartland Advisors Inc. (1.76%), Renaissance Technologies LLC (1.31%), Dimensional Fund Advisors LP (1.28%), Smith Graham & Co. Investment Advisors LP (1.18%) and Morgan Stanley (1.15%). Insiders that own company stock include E Thomas Corcoran and Larry Lee Miller.
View institutional ownership trends
.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $14.53.

How much money does Phibro Animal Health make?

Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $588.52 million and generates $972.05 million in revenue each year. The company earns $49.17 million in net income (profit) each year or $0.90 on an earnings per share basis.

How many employees does Phibro Animal Health have?

The company employs 1,860 workers across the globe.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.

This page (NASDAQ:PAHC) was last updated on 3/24/2023 by MarketBeat.com Staff